Clinical aspects of antenatal glucocorticoid treatment for prevention of neonatal respiratory distress syndrome

Artikel in diesem Heft

1. Titelei
2. Guest editorial
3. Announcements
4. Actual state in the diagnosis of fetal lung maturity
5. Pathway of significance for the synthesis of pulmonary surfactant
6. Consequences of asphyxia in surfactant deficiency
7. Pregnancy-related factors and diseases influencing surfactant
8. Clinical aspects of antenatal glucocorticoid treatment for prevention of neonatal respiratory distress syndrome
9. New approaches to hormonal acceleration of fetal lung maturation
10. Alternatives to the antenatal glucocorticoid treatment for the prevention of respiratory distress syndrome
11. Round table discussion. Diagnosis of fetal lung maturity and antenatal treatment
12. Natural surfactant substitution in respiratory distress syndrome
13. Surfactant substitution in the newborn by application of artificial surfactant
14. Surfactant can be supplemented before the neonate needs it
15. Round table discussion.Future programs in the basic and clinical sciences on surfactant Stimulation and substitution
16. Guidelines for the preparation of manuscripts